Chapter 1 Mitochondrial ROS and Apoptosis

Chapter 2 Dopamine Metabolism and Reactive Oxygen Species Production

Chapter 3 The Consequences of Damaged Mitochondrial DNA

Chapter 5 Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease

Chapter 6 Toxin-Mediated Complex I Inhibition and Parkinson’s Disease

Chapter 7 Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function

Chapter 8 PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria

Chapter 9 Mitochondrial Therapeutic Approaches in Parkinson’s Disease

Chapter 10 Altering Mitochondrial Fusion and Fission Protein Levels Rescues Parkin and PINK1 Loss-of-Function Phenotypes

Chapter 11 Early Nicotine Exposure Is Protective in Familial and Idiopathic Models of Parkinson’s Disease

Chapter 12 Transcription Modulation of Mitochondrial Function and Related Pathways as a Therapeutic Opportunity in Parkinson’s Disease

Chapter 13 Delivery of Biologically Active Molecules to Mitochondria